These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24423609)

  • 1. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
    Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
    Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2.
    Li H; Zhao L; Zhang Z; Zhang H; Ding C; Su Z
    Tumour Biol; 2017 Oct; 39(10):1010428317719274. PubMed ID: 29025376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
    Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
    Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Frequent Overexpression of
    Clin Cancer Res; 2017 Jun; 23(12):3225. PubMed ID: 28620002
    [No Abstract]   [Full Text] [Related]  

  • 5. Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data.
    Bianchini L; Saâda E; Gjernes E; Marty M; Haudebourg J; Birtwisle-Peyrottes I; Keslair F; Chignon-Sicard B; Chamorey E; Pedeutour F
    Genes Chromosomes Cancer; 2011 Jun; 50(6):442-55. PubMed ID: 21412931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
    Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
    Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.
    Suzuki M; Kondo A; Ogino I; Arai H; Tomita T; Sredni ST
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
    Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
    BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
    Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells.
    Vu-Han TL; Frühwald MC; Hasselblatt M; Kerl K; Nagel I; Obser T; Oyen F; Siebert R; Schneppenheim R
    Cancer Genet; 2014 Sep; 207(9):390-7. PubMed ID: 25016934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tough decoy targeting of predominant let-7 miRNA species in adult human hematopoietic cells.
    de Vasconcellos JF; Byrnes C; Lee YT; Allwardt JM; Kaushal M; Rabel A; Miller JL
    J Transl Med; 2017 Aug; 15(1):169. PubMed ID: 28768505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
    Ye H; Chen J; Huang X; Guo A; Hao P
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
    Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
    PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
    Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
    Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.